EU projects
The development of our company and product potential, as well as research and development work, is financed from our own resources and from external funding, including EU funding. Find out about our latest development projects.
‘Use of renewable energy sources at Arkona Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk’.
as part of the Regional Operational Programme for the Lubelskie Voivodeship 2014-2020, Priority Axis: 15 Resilient Lubelskie – REACT-EU resources for Lubelskie, Measure: 15.1 Support for enterprises in the field of energy.
Project objective: The main objective of the project is to increase the use of renewable energy sources in the production of electricity, as well as to reduce emissions of pollutants, including CO2 into the atmosphere.
Planned effects:
- Reduction in the consumption of energy produced from conventional sources.
- Electricity production from the newly built photovoltaic installation.
- Increased awareness of the local community regarding renewable energy sources.
- Positive impact on environmental protection, e.g. by reducing CO2 emissions into the atmosphere.
- Reduction of business costs.
Project value: 392 368.69 PLN
EU co-financing of the project: 175,449.40 PLN
Beneficiary: Arkona Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk’
ARKONA Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk is implementing a project entitled: ‘Grant for working capital for Arkona Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk’.
As part of Measure 1.5 Subsidies for working capital under the Eastern Poland Regional Operational Programme 2014-2020.
The project relates to the support of the entrepreneur in terms of ensuring financial liquidity and support of current activities in connection with financial difficulties experienced by the entrepreneur as a result of the COVID-19 outbreak. Financial assistance provided under programme no. SA.57015 (2020/N).
Project value: PLN 100,939.53
European Funds contribution: PLN 100,939.53
ARKONA Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk is implementing the project entitled: ‘Internationalisation of the company ARKONA Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk by implementing the Business Model of Internationalisation’.
Within the framework of the Operational Programme Eastern Poland 2014-2020, Priority Axis 1:
‘Entrepreneurial Eastern Poland’, Measure 1.2 Internationalisation of SMEs, co-financed by the European Regional Development Fund.
The aim of the project is to introduce ARKONA Laboratorium Farmakologii Stomatologicznej Grzegorz Kalbarczyk products to new foreign markets.
The effect of the project will be an increase in economic activity and a strengthening of the company’s position on the international market.
Total value of the project: 897 103 PLN
Value of eligible costs: 764 600 PLN
European Funds’ contribution: 649 910 PLN
ARKONA LABORATORIUM FARMAKOLOGII STOMATOLOGICZNEJ GRZEGORZ KALBARCZYK implements the project entitled. ‘Implementation of technological innovation in the activities of the company ARKONA LABORATORIUM FARMAKOLOGII STOMATOLOGICZNEJ’.
under Sub-action 3.2.2: Credit for technological innovation, Operational Programme Intelligent Development 2014-2020 co-financed by the European Regional Development Fund.
The aim of the project is to implement the developed technological innovation. As a result of the project, on the basis of the developed technology, the production of innovative medical products supporting the treatment of inflammatory conditions in the oral cavity and throat will be launched.
Project results: As a result of the implementation of the project, the material scope consisting in the construction of a new production plant and the purchase of fixed assets constituting the equipment of the production line will be realised. Thanks to the implementation of the project, ARKONA will gain the technical and organisational capacity to start production and implement the technological innovation on the market. The developed technological innovation will enable significant changes to be made in the process of bottling finished products on the production line.
The implementation of the project will contribute to the main objectives of the company’s strategy by:
- increase in production capacity
- increase in the scale of operations of the company
- an increase in the company’s competitiveness through the implementation of innovative technologies and products
- increase in the intellectual potential of the company as a producer of medical devices implementing
- own innovations being the subject of intellectual property protection increase in employment
Project value: 10,862,639.46 PLN
Value of eligible costs: 8 548 849.78 PLN
European Funds’ contribution: 5 984 194.84 PLN
